Sean A. McCarthy
2022
In 2022, Sean A. McCarthy earned a total compensation of $3M as Chief Executive Officer and Chairman of the Board of Directors at CytomX Therapeutics, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $397,553 |
|---|---|
| Option Awards | $1,559,160 |
| Salary | $622,893 |
| Stock Awards | $429,000 |
| Other | $5,000 |
| Total | $3,013,606 |
McCarthy received $1.6M in option awards, accounting for 52% of the total pay in 2022.
McCarthy also received $397.6K in non-equity incentive plan, $622.9K in salary, $429K in stock awards and $5K in other compensation.
Rankings
In 2022, Sean A. McCarthy's compensation ranked 1,213th out of 5,760 executives tracked by ExecPay. In other words, McCarthy earned more than 78.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,213 out of 5,760 | 79th |
Division Manufacturing | 586 out of 3,136 | 81st |
Major group Chemicals And Allied Products | 215 out of 1,422 | 85th |
Industry group Drugs | 194 out of 1,323 | 85th |
Industry Pharmaceutical Preparations | 145 out of 969 | 85th |
Source: SEC filing on April 27, 2023.
McCarthy's colleagues
We found four more compensation records of executives who worked with Sean A. McCarthy at CytomX Therapeutics in 2022.